Cancer News
OncoLink Cancer News - HealthDay

Study suggests high number of regulatory T cells can help predict risk of squamous cell skin cancer

-- A. Agrawal, PhD

Friday, January 29, 2010 (Last Updated: 02/01/2010)

FRIDAY, Jan. 29 (HealthDay News) -- Components of the immune system, particularly high numbers of regulatory T cells, predict whether a kidney transplant recipient is likely to develop a type of skin cancer, according to a study published online Jan. 28 in the Journal of the American Society of Nephrology.

Robert P. Carroll, of the John Radcliffe Hospital in Oxford, U.K., and colleagues examined whether elements of the immune system could be linked to the risk of developing cutaneous squamous cell cancer (SCC) in 110 kidney transplant recipients, where 60 patients had SCC and 50 matched patients did not.

During a median follow-up of 340 days, the researchers found that the risk of developing new cutaneous SCC was higher in patients with high numbers of peripheral FOXP3+, CD4+, CD127low regulatory T cells (hazard ratio, 2.48), low numbers of natural killer cells (hazard ratio, 5.6), and previous SCC (hazard ratio, 1.33). A low ratio of CD8 to FOXP3+ was present in cutaneous SCC from kidney transplant recipients compared with matched SCC from patients not receiving a kidney transplant, and was associated with the development of new cutaneous SCC.

"In summary, monitoring components of the immune system can predict development of cutaneous SCC among kidney transplant recipients," Carroll and colleagues conclude. "If similar immune phenotypes are predictive in other kidney transplant recipient populations, then immune phenotype method has the potential to inform immunosuppressive regimen manipulation in kidney transplant recipients at high risk for developing multiple SCCs."

Full Text (subscription or payment may be required)

Specialties Oncology
Internal Medicine

Copyright © 2010 HealthDay. All rights reserved.

I Wish You Knew

There is help to get you through cancer treatment

View More

Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.

OncoLink OncoPilot

Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!

Learn More